Related Experiment Video
Updated: Jul 13, 2026

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
Role of c-Abl in directing metabolic versus mitogenic effects in insulin receptor signaling
Francesco Frasca1, Giuseppe Pandini, Roberta Malaguarnera
1Endocrinologia, Dipartimento di Medicina Interna e di Medicina Specialistica, Università di Catania, Ospedale Garibaldi, Nesima, 95122 Catania, Italy. f.frasca@unict.it
Abstract:
c-Abl is a cytoplasmic tyrosine kinase involved in several signal transduction pathways. Here we report that c-Abl is involved also in insulin receptor signaling. Indeed, c-Abl tyrosine kinase is activated upon insulin stimulation. Inhibition of c-Abl tyrosine kinase by STI571 attenuates the effect of insulin on Akt/GSK-3beta phosphorylation and glycogen synthesis, and at the same time, it enhances the effect of insulin on ERK activation, cell proliferation, and migration. This effect of STI571 is specific to c-Abl inhibition, because it does not occur in Abl-null cells and is restored in c-Abl-reconstituted cells. Numerous evidences suggest that focal adhesion kinase (FAK) is involved in mediating this c-Abl effect. First, anti-phosphotyrosine blots indicate that c-Abl tyrosine kinase activation is concomitant with FAK dephosphorylation in response to insulin, whereas c-Abl inhibition is accompanied by FAK phosphorylation in response to insulin, a response similar to that observed with IGF-I. Second, the c-Abl effects on insulin signaling are not observed in cells devoid of FAK (FAK(-/-) cells). Taken together these results suggest that c-Abl activation by insulin, via a modification of FAK response, may play an important role in directing mitogenic versus metabolic insulin receptor signaling.
Insights
The cytoplasmic tyrosine kinase, c-Abl, plays a key role in insulin signaling by influencing focal adhesion kinase (FAK) activity. Inhibiting c-Abl kinase activity alters insulin
Area of Science:
- Cellular signaling
- Biochemistry
- Molecular biology
Background:
- c-Abl is a cytoplasmic tyrosine kinase.
- c-Abl participates in various signal transduction pathways.
- Its role in insulin receptor signaling was previously unclear.
Purpose of the Study:
- To investigate the involvement of c-Abl in insulin receptor signaling.
- To elucidate the downstream effects of c-Abl activation or inhibition in response to insulin.
- To determine the role of focal adhesion kinase (FAK) in mediating c-Abl's effects on insulin signaling.
Main Methods:
- Utilized STI571 to inhibit c-Abl tyrosine kinase activity.
- Examined insulin-stimulated phosphorylation of Akt/GSK-3beta and ERK.
- Assessed glycogen synthesis, cell proliferation, and migration.
- Employed Abl-null and c-Abl-reconstituted cells to confirm specificity.
- Investigated FAK phosphorylation status and utilized FAK(-/-) cells.
Main Results:
- Insulin stimulation activates c-Abl tyrosine kinase.
- c-Abl inhibition by STI571 attenuates insulin's effects on Akt/GSK-3beta phosphorylation and glycogen synthesis.
- c-Abl inhibition enhances insulin's effects on ERK activation, cell proliferation, and migration.
- These effects are specific to c-Abl and mediated through FAK.
- Insulin stimulation leads to c-Abl activation and FAK dephosphorylation, while c-Abl inhibition results in FAK phosphorylation.
Conclusions:
- Insulin receptor signaling involves c-Abl activation.
- c-Abl modulates FAK response to insulin.
- c-Abl plays a critical role in directing the balance between mitogenic and metabolic insulin signaling pathways.
More Related Videos
Related Concept Videos
Insulin: The Receptor and Signaling Pathways
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
cAMP-dependent Protein Kinase Pathways
PI3K/mTOR/AKT Signaling Pathway
Amplifying Signals via Enzymatic Cascade
Regulation of Metabolism

